We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info . X close

Minimally Invasive Surgery Market: Growth, Size, Share, and Trends

Report Code MD 1250
Published in Jul, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Minimally Invasive Surgery Market by Type (Surgical Device, Imaging System, Electrosurgical Device, Endoscopy Device, Medical Robotics), Application (Urological, Vascular, Oncological), End User (Hospital, Clinic, ASC) Region-Global Forecast to 2030

Overview

The global minimally invasive surgery market, valued at US$81.65 billion in 2024, stood at US$94.45 billion in 2025 and is projected to advance at a resilient CAGR of 16.1% from 2025 to 2030, culminating in a forecasted valuation of US$199.30 billion by the end of the period. The growth of the minimally invasive surgery market is fueled by the increasing preference for faster recovery, less postoperative pain, and shorter hospital stays among patients and healthcare providers. Technological developments such as robotic-assisted systems, AI-enabled imaging, and 3D visualization further improve surgical accuracy and outcomes. Opportunities arise from the expanding geriatric population needing chronic disease management, rising outpatient surgical procedures, and the growing demand for MIS procedures in outpatient settings. Additionally, expanding healthcare infrastructure and training programs in emerging markets will likely present significant opportunities for MIS device manufacturers during the forecast period.

Minimally Invasive Surgery Market – Global Forecast and Key Opportunities to 2030

Attractive Opportunities in the Minimally Invasive Surgery Market

Asia Pacific

Market growth in the Asia Pacific can be attributed to the increasing prevalence of chronic diseases and the increasing adoption of minimally invasive surgeries across the region.

Growth in this market can be attributed to the increasing number of hospitals and surgeries and the growing adoption of minimally invasive procedures over open surgeries.

In the next five years, the increasing adoption of advanced robotics in ambulatory surgical centers is expected to offer lucrative opportunities for market players.

The Asia Pacific market is projected to grow at the fastest CAGR in the minimally invasive surgery market.

The high cost of robotic systems restrains the market growth to a certain extent, and the changing regulatory landscape in medical devices is challenging the market growth.

Global Minimally Invasive Surgery Market Dynamics

DRIVER: Increasing adoption of minimally invasive surgery over open surgeries

The rising adoption of minimally invasive surgeries (MIS) over traditional open surgeries is a key driver of the growth in the minimally invasive surgery market. MIS techniques—such as laparoscopy, endoscopy, and robotic-assisted procedures—are becoming more popular because they often yield better clinical outcomes with less physical trauma. These procedures involve smaller incisions, leading to less postoperative pain, quicker recovery times, minimal scarring, and a lower risk of complications like infections and blood loss. This boosts patient satisfaction and results in shorter hospital stays and lower overall healthcare costs, aligning with the global move toward value-based care models. Hospitals, outpatient surgery centers, and payers increasingly favor MIS for its efficiency and ability to better utilize resources. Furthermore, advances in imaging technologies, robotics, and precision surgical tools make MIS more accessible and useful across many specialties, including gynecology, urology, orthopedics, gastrointestinal, and cardiothoracic surgeries. Growing training and education in MIS techniques have expanded surgeon capabilities, especially in emerging markets. As populations age and healthcare systems aim for improved patient outcomes at lower costs, the preference for MIS over open surgery continues to grow, fueling sustained global market expansion.

RESTRAINT: High system costs, long investment cycles, and low ROIs

The high cost of robotic surgical systems significantly limits the growth of the minimally invasive surgery market, especially in cost-sensitive and publicly funded healthcare settings. For example, a single robotic platform like the da Vinci Surgical System costs between USD 0.5 million and USD 2.5 million, depending on the model, configuration, and location. However, this price does not include substantial indirect costs, such as an annual service fee of up to USD 190,000 and recurring expenses for instruments and accessories, which range between USD 600 and USD 3,500 per procedure. These expenses can heavily impact operating margins, particularly for mid-sized hospitals and developing markets. Additionally, the total cost of ownership includes installation, maintenance, software upgrades, and specialized surgeon training, further increasing the financial burden. In some regions, reimbursement uncertainties and unclear return on investment (ROI) add to the challenge. While robotic-assisted MIS provides advanced clinical benefits, the high cost structure limits broader market adoption. Overcoming this barrier will require value-based pricing, cost-reduction strategies, and technological innovations to improve affordability and expand use across various healthcare environments.

 

OPPORTUNITY: Increasing adoption of advanced robotics in Ambulatory Surgical Centers (ASCs)

The growing use of advanced robotics in Ambulatory Surgical Centers (ASCs) presents a major growth opportunity for the minimally invasive surgery market. ASCs provide a cost-effective and efficient alternative to traditional hospital-based surgeries, with costs typically 35% to 50% lower, making them a preferred option for governments, insurers, and patients looking to reduce healthcare expenses while maintaining quality care. The need for cost control and better operational efficiency has driven the move of surgeries from hospital operating rooms to ASCs. This trend is further sped up by the integration of orthopedic robotics and enabling technologies designed to meet the precise needs of MIS while being compact and affordable enough to function in ASC settings. As robotic-assisted surgeries become more accessible in outpatient environments, the number of MIS procedures is expected to grow significantly. This shift not only broadens the reach of MIS to more patients but also enhances ASCs’ role as a scalable and appealing healthcare delivery option. As a result, the spread of robotic systems in ASCs will play a key part in expanding the global market during the forecast period.

CHALLENGES: Changing regulatory landscape in medical devices

The evolving regulatory landscape in the medical device industry presents a major obstacle to the growth of the minimally invasive surgery market. The transition from the EU Medical Device Directive (MDD) to the more rigorous Medical Device Regulation (MDR) has increased complexity, requiring detailed documentation, clinical assessments, and stricter oversight. This change has resulted in longer product approval times and higher regulatory costs, which slow innovation and delay the entry of new MIS technologies into the market. Additionally, countries such as the US, China, and India are tightening their regulations, focusing on post-market surveillance, real-world evidence, and patient safety. For global companies, adjusting to these varied and evolving regulatory standards significantly raises operational challenges and demands more financial and human resources. Startups and small to mid-sized firms are especially affected, often lacking the capacity to manage these complex regulations, creating barriers to market access. This dynamic regulatory environment is a bottleneck for the timely launch and worldwide distribution of MIS technologies. Consequently, it not only hampers technological progress but also restricts the availability and affordability of minimally invasive solutions, particularly in cost-sensitive or resource-limited settings, ultimately constraining the overall growth of the global minimally invasive surgery market.

Global Minimally Invasive Surgery Market Ecosystem Analysis

The ecosystem of the minimally invasive surgery market is complex and multifaceted, involving a wide range of stakeholders and components. It includes key products such as surgical devices, imaging and visualization systems, endoscopy equipment, electrosurgical tools, and advanced medical robotics—each vital in providing precise and less invasive surgical procedures. The market is divided into various surgical applications, including gastrointestinal, cardiothoracic, orthopedic, gynecological, vascular, neurological, urological, oncological, ENT, cosmetic, and dental surgeries, demonstrating its wide clinical use. End users include hospitals, specialty clinics, ambulatory surgical centers (ASCs), and emergency & trauma centers, all contributing to adoption based on procedure volume, care setting, and budget. The value chain extends beyond manufacturers to include distributors, after-sales service providers, regulatory agencies, and training organizations, all ensuring accessibility, compliance, and operational continuity. Collaboration among these ecosystem players is essential for fostering innovation, streamlining regulatory processes, optimizing supply chains, and expanding the global reach of MIS products.

Minimally Invasive Surgery Market Ecosystem

By product, the ultrasound systems segment held the highest market share by the type of imaging & visualization systems in 2024 across the minimally invasive surgery market.

Based on product, the global minimally invasive surgery market is divided into surgical devices, imaging & visualization systems, electrosurgical devices, endoscopy devices, and medical robotics. Among these, the imaging & visualization systems segment is expected to grow fastest during the forecast period. This segment is further divided into ultrasound systems, CT systems, MRI systems, X-ray systems, and other visualization systems. In 2024, the ultrasound systems segment held the largest market share within this category. This is because of their versatility, affordability, and safety profile. Unlike other imaging methods like CT or MRI, ultrasound provides real-time, radiation-free imaging, making it ideal for guiding many MIS procedures. The long-standing use of 2D ultrasound in diagnostic accuracy, along with the increasing adoption of advanced techniques such as Doppler ultrasound for vascular imaging and 3D/4D ultrasound in oncology and obstetrics, has greatly expanded its clinical use. It can assess organs like the liver, kidneys, heart, uterus, and fetal development, supporting its broad utility across various specialties. Furthermore, ultrasound machines tend to be more affordable, portable, and easy to operate, enabling integration into busy hospital environments as well as resource-limited settings like ambulatory surgical centers (ASCs). This combination of precision, support for procedures, and operational efficiency makes ultrasound systems a vital and leading part of the imaging infrastructure in MIS.

The urological surgery segment of the minimally invasive surgery market is expected to grow at the fastest CAGR across the forecast period.

Based on application, the minimally invasive surgery market is divided into cardiothoracic surgery, vascular surgery, neurological surgery, ENT & respiratory surgery, cosmetic surgery, gastrointestinal & abdominal surgery, gynecological surgery, urological surgery, orthopedic surgery, oncology surgery, dental surgery, and other surgeries. Of these, the urological surgery segment is expected to grow the fastest during the forecast period. This is due to the increasing global burden of urological conditions such as prostate and bladder cancers, as well as complex renal calculi. According to the World Cancer Research Fund, there were 1,467,854 new cases of prostate cancer and 614,298 new cases of bladder cancer worldwide in 2022. The International Agency for Research on Cancer also reported over 600,000 new bladder cancer diagnoses and more than 220,000 related deaths, emphasizing the urgent need for effective surgical intervention. Minimally invasive laparoscopic procedures provide a safe and effective treatment option for complex urological conditions, replicating traditional open techniques such as nephrectomy, pyeloplasty, and nephrolithotomy while reducing surgical trauma, hospital stays, and recovery times. Furthermore, in the US alone, the American Cancer Society estimates over 313,000 new cases of prostate cancer and nearly 36,000 deaths in 2025, further increasing the demand for efficient and less invasive treatment options. As awareness, early diagnosis, and surgical precision improve, healthcare providers are increasingly adopting MIS for urological procedures, especially in high-prevalence areas. This strong clinical demand, combined with technological advancements, is driving significant growth in the urological surgery segment.

By Region, the Asia Pacific is Expected to Showcase the Highest CAGR During the Forecast Period.

Based on the region, the minimally invasive surgery market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. During the forecast period, Asia Pacific is expected to be the fastest-growing regional market for minimally invasive surgery. This growth is primarily driven by its rapidly aging population, the increasing prevalence of chronic diseases, and the rising adoption of advanced surgical technologies. In India, about 21% of the elderly population reportedly suffers from at least one chronic disease, with a higher prevalence in urban areas (29%) compared to rural areas (17%), according to the National Library of Medicine (2022). Similarly, China, which has one of the world’s largest aging populations—36.23 million people over the age of 65 and more than 10% aged 80 or older—is experiencing an exponential increase in chronic disease cases. An article in BMC Medical Education from 2024 states that China performs over 10 million laparoscopic surgeries annually. Moreover, the national prevalence of chronic diseases among elderly Chinese adults is 81.1%, amounting to nearly 180 million individuals. These demographic and epidemiological trends are fueling a strong demand for cost-effective, less invasive surgical options. Additionally, advancements in healthcare infrastructure, increased government investment, and growing awareness of the benefits of MIS are accelerating their adoption in emerging economies. Collectively, these factors position the Asia Pacific region as the fastest-growing area in the global minimally invasive surgery market during the forecast period.

REGION HOLDS LARGEST SHARE IN 2024
ASIA PACIFIC FASTEST-GROWING MARKET IN REGION
Minimally Invasive Surgery Market Region

Recent Developments of Minimally Invasive Surgery Market

  • In July 2025, Zimmer Biomet Holdings, Inc. announced its acquisition of Monogram Technologies Inc., aiming to enhance the ROSA® Robotics platform with Monogram’s autonomous robotic technologies. This move is intended to strengthen its navigation and enabling technology portfolio for surgical precision.
  • In July 2025, Intuitive Surgical announced FDA clearance for its latest innovation—the Vessel Sealer Curved, an advanced energy instrument designed to improve surgical efficiency and versatility across its multiport da Vinci robotic systems.
  • In May 2025, the company Intuitive Surgical announced FDA clearance for the da Vinci Single Port (SP) surgical system for transanal local excision/resection, enabling minimally invasive, incision-free access through a natural orifice for select case procedures.
  • In March 2025, FUJIFILM Corporation announced the commercial launch of its EN-840T Double Balloon Enteroscopy (DBE) scope—an advanced endoscopic imaging solution designed to provide comprehensive access to the entire small intestine for both diagnostic and therapeutic purposes applications.
  • In December 2024, Siemens Healthineers AG expanded its portfolio with the launch of the Naeotom Alpha class, introducing the Naeotom Alpha.Pro¹—its second dual-source scanner—and the Naeotom Alpha. Prime, the world’s first single-source scanner featuring photon-counting technology, sets new standards in CT imaging precision innovation.

Key Market Players

KEY PLAYERS IN THE MINIMALLY INVASIVE SURGERY MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Minimally Invasive Surgery Market?

Scope of the Report

Report Metric Details
Market size available for years 2020-2030
Base Year Considered 2024
Forecast period 2025-2030
Forecast units Value (USD Million/Billion)
Segments covered Product, Application, End User, and Region
Geographies covered North America (US and Canada), Europe (Germany, UK, France, Italy, Spain, and Rest of Europe), Asia Pacific (Japan, China, Australia, South Korea, India, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, RoMEA)

Key Questions Addressed by the Report

Which are the top industry players in the global minimally invasive surgery market?

The prominent players in this market are Medtronic (Ireland), Johnson & Johnson (US), Stryker (US), Boston Scientific Corporation (US), Siemens Healthineers AG (Germany), Abbott (US), GE HealthCare (US), Koninklijke Philips N.V. (Netherland), Intuitive Surgical Operations, Inc. (US), FUJIFILM Corporation (Japan).

What are some of the major drivers for this market?

Increasing number of hospitals and surgeries, rising adoption of MIS over open surgeries, and advantages of robot-assisted surgery & training in rehabilitation therapy to favor market growth.

Which end users have been included in the global minimally invasive surgery market?

This report contains the following end-user segments:

  • Hospitals
  • Clinics
  • Emergency & Trauma Centers
  • Ambulatory Surgery Center
  • Other End Users

 

Which type of application of minimally invasive surgery is holding the highest market share in the minimally invasive surgery market?

The gastrointestinal & abdominal surgery segment is holding the highest market share in the minimally invasive surgery market.

Which region is lucrative for the minimally invasive surgery market?

The Asia Pacific market is expected to witness the highest CAGR during the forecast period.

Adjacent Markets

Request Bundle Reports

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Minimally Invasive Surgery Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
34
RESEARCH METHODOLOGY
40
EXECUTIVE SUMMARY
53
PREMIUM INSIGHTS
57
MARKET OVERVIEW
61
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Rising geriatric population and increasing number of surgeries
    - Growing adoption of minimally invasive surgeries over traditional open surgical procedures
    - Advantages of robot-assisted surgery and training in rehabilitation therapy
    RESTRAINTS
    - High cost of robotic systems
    OPPORTUNITIES
    - High growth opportunities in emerging markets
    - Increasing adoption of advanced robotics in ambulatory surgery centers
    CHALLENGES
    - Changing regulatory landscape in medical device industry
  • 5.3 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Laparoscopy
    - Electrosurgery
    COMPLEMENTARY TECHNOLOGIES
    - Robotic surgery
    - Medical and surgical imaging
    ADJACENT TECHNOLOGIES
    - Artificial intelligence and machine learning
  • 5.4 INDUSTRY TRENDS
    INTEGRATION OF ARTIFICAL INTELLIGENCE AND MACHINE LEARNING
    TECHNOLOGICAL ADVANCEMENTS IN IMAGING
  • 5.5 VALUE CHAIN ANALYSIS
  • 5.6 ECOSYSTEM ANALYSIS
  • 5.7 SUPPLY CHAIN ANALYSIS
  • 5.8 TRADE ANALYSIS
    IMPORT DATA FOR HS CODE 9018, 2019–2024
    EXPORT SCENARIO FOR HS CODE 9018, 2019–2024
  • 5.9 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF BUYERS
    BARGAINING POWER OF SUPPLIERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.10 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA
  • 5.11 REGULATORY ANALYSIS
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY FRAMEWORK
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    - Middle East & Africa
  • 5.12 PATENT ANALYSIS
    INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
  • 5.13 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND OF MINIMALLY INVASIVE SURGICAL PRODUCTS, BY KEY PLAYER
    AVERAGE SELLING PRICE TREND OF MINIMALLY INVASIVE SURGICAL PRODUCTS, BY REGION, 2022–2024
  • 5.14 KEY CONFERENCES & EVENTS, 2025–2026
  • 5.15 ADJACENT MARKET ANALYSIS
    ENDOSCOPY EQUIPMENT MARKET
  • 5.16 UNMET NEEDS/END-USER EXPECTATIONS
  • 5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • 5.18 INVESTMENT & FUNDING SCENARIO
  • 5.19 IMPACT OF AI/GEN AI ON MINIMALLY INVASIVE SURGERY MARKET
  • 5.20 IMPACT OF 2025 US TARIFF ON MINIMALLY INVASIVE SURRGERY MARKET
    INTRODUCTION
    KEY TARIFF RATES
    PRICE IMPACT ANALYSIS
    KEY IMPACT ON COUNTRY/REGION
    - North America
    - Europe
    - Asia Pacific
    IMPACT ON END-USE INDUSTRIES
MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT
94
  • 6.1 INTRODUCTION
  • 6.2 SURGICAL DEVICES
    HANDHELD INSTRUMENTS
    - Tubular retractors
    - Dilators
    - Suturing instruments
    - Probes
    - Laser fiber devices
    LAPAROSCOPY DEVICES
    - Laparoscopes
    - Trocars & cannulas
    - Graspers & dissectors
    INFLATION SYSTEMS
    - Balloon catheters
    - Balloon inflation systems
    GUIDING DEVICES
    - Guiding catheters
    - Guidewires
  • 6.3 IMAGING & VISUALIZATION SYSTEMS
    ULTRASOUND SYSTEMS
    - Rising chronic disease burden to drive demand for reliable, non-invasive ultrasound imaging
    - CT scanners
    MRI SYSTEMS
    - Rising cancer prevalence to increase reliance on MRI for early detection and image-guided surgeries
    X-RAY SYSTEMS
    - Rapid, low-cost digital imaging and high patient throughput to favor market growth
    OTHER IMAGING & VISUALIZATION SYSTEMS
  • 6.4 ELECTROSURGAL DEVICES
    ELECTROCAUTERY DEVICES
    - High demand for precise cutting and coagulation to boost electrocautery device use in minimally invasive procedures
    ELECTROSURGICAL GENERATORS & ACCESSORIES
    - Growing use of disposables and reusable instruments to propel segment growth
  • 6.5 ENDOSCOPY DEVICES
    RIGID ENDOSCOPES
    - Rising joint and urologic disorders to drive demand in high-volume minimally invasive surgeries
    FLEXIBLE ENDOSCOPES
    - Increased preventive screening and early cancer detection to elevate flexible endoscope adoption
  • 6.6 MEDICAL ROBOTICS
    ROBOTIC SYSTEMS
    - Superior precision, enhanced control, and ability to perform complex procedures with greater dexterity to drive market
    ROBOTIC INSTRUMENTS
    - Growing volume of robotic surgical procedures to augment market growth
    ROBOTIC SOFTWARE & SERVICES
    - Rising robotic installations to increase demand for bundled training, maintenance, and technical support services
MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION
135
  • 7.1 INTRODUCTION
  • 7.2 GASTROINTESTINAL & ABDOMINAL SURGERY
    RISING GLOBAL BURDEN OF GASTROINTESTINAL CANCERS AND DIGESTIVE DISORDERS TO DRIVE MARKET
  • 7.3 CARDIOTHORACIC SURGERY
    INCREASING CARDIOVASCULAR AND THORACIC CONDITIONS TO INCREASE PRECISION-BASED MINIMALLY INVASIVE PROCEDURES
  • 7.4 ORTHOPEDIC SURGERY
    RISING BURDEN OF MUSCULOSKELETAL DISORDERS AND GROWING GERIATRIC POPULATION TO AID MARKET GROWTH
  • 7.5 VASCULAR SURGERY
    MINIMALLY INVASIVE VASCULAR SURGERY PRODUCTS TO REPLACE CONVENTIONAL SUTURE-BASED METHODS
  • 7.6 GYNECOLOGICAL SURGERY
    HIGH INCIDENCE OF GYNECOLOGICAL DISORDERS TO FUEL SEGMENT GROWTH
  • 7.7 ONCOLOGICAL SURGERY
    HIGH CANCER INCIDENCE AND ADOPTION OF ADVANCED PRECISION SURGICAL TECHNOLOGIES TO BOOST MARKET GROWTH
  • 7.8 NEUROLOGICAL SURGERY
    INCREASING GERIATRIC POPULATION AND RISING OCCURRENCE OF NEURODEGENERATIVE DISORDERS TO PROPEL MARKET GROWTH
  • 7.9 UROLOGICAL SURGERY
    INCREASING PREVALENCE OF UROLOGICAL CANCERS TO AUGMENT MARKET GROWTH
  • 7.10 ENT & RESPIRATORY SURGERY
    GROWING GLOBAL BURDEN OF COPD AND HEAD & NECK CANCERS TO DRIVE MARKET
  • 7.11 COSMETIC SURGERY
    HIGH DEMAND FOR AESTHETIC ENHANCEMENT WITH MINIMAL DOWNTIME TO PROPEL MARKET GROWTH
  • 7.12 DENTAL SURGERY
    RISING PATIENT DEMAND FOR LESS PAINFUL AND TISSUE-PRESERVING TREATMENTS TO FAVOR MARKET GROWTH
  • 7.13 OTHER SURGERIES
MINIMALLY INVASIVE SURGERY MARKET, BY END USER
149
  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS
    RISING CHRONIC DISEASE BURDEN TO DRIVE PATIENT PREFERENCE FOR ADVANCED MINIMALLY INVASIVE SURGERIES IN HOSPITALS
  • 8.3 AMBULATORY SURGERY CENTERS
    GROWING PATIENT PREFERENCE FOR QUICKER DISCHARGE AND LOWER COSTS TO BOOST MARKET GROWTH
  • 8.4 CLINICS
    PREFERENCE FOR OUTPATIENT AND COST-EFFECTIVE MINIMALLY INVASIVE SURGICAL PROCEDURES TO AID MARKET GROWTH
  • 8.5 EMERGENCY & TRAUMA CENTERS
    INCREASING DEMAND FOR SAME-DAY SURGERIES TO AUGMENT MARKET GROWTH
  • 8.6 OTHER END USERS
MINIMALLY INVASIVE SURGERY MARKET, BY REGION
156
  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - US to dominate North American minimally invasive surgery market during forecast period
    CANADA
    - High geriatric population with chronic diseases to propel market growth
  • 9.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Increased cancer incidence and strong healthcare infrastructure to fuel market growth
    UK
    - Increasing geriatric population and rising need for oncological surgeries to stimulate market growth
    FRANCE
    - High burden of non-communicable diseases to accelerate demand for minimally invasive procedures
    ITALY
    - Increasing geriatric population to support adoption of minimally invasive procedures in degenerative conditions
    SPAIN
    - Robust public healthcare and focus on reduced post-operative complications to augment market growth
    REST OF EUROPE
  • 9.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    CHINA
    - Growing need for less invasive and high-precision surgical interventions to drive market
    INDIA
    - Need for cost-effective and efficient surgical options in resource-constrained healthcare system to drive adoption
    JAPAN
    - Advanced medical technology adoption and strong focus on patient-centric care to accelerate market growth
    SOUTH KOREA
    - High demand for plastic surgeries and adoption of advanced robotics to aid market growth
    AUSTRALIA
    - Increasing chronic disease burden and booming cosmetic surgery rates to fuel market expansion
    REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Substantial public health investment and advanced dual public-private healthcare system to favor market growth
    MEXICO
    - Rising obesity across age groups to fuel demand for minimally invasive surgical procedures in Mexican healthcare system
    REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - Increased government healthcare investments and adoption of advanced medical technologies to spur market growth
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
288
  • 10.1 INTRODUCTION
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MINIMALLY INVASIVE SURGERY MARKET
  • 10.3 REVENUE ANALYSIS, 2020–2024
  • 10.4 MARKET SHARE ANALYSIS, 2024
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2024
    - Company footprint
    - Region footprint
    - Product footprint
    - Application footprint
    - End-user footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    - Detailed list of key startups/SMEs
    - Competitive benchmarking of key startups/SMEs
  • 10.7 COMPANY VALUATION & FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 10.8 BRAND/PRODUCT COMPARISON
  • 10.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES AND APPROVALS
    DEALS
COMPANY PROFILES
307
  • 11.1 KEY PLAYERS
    MEDTRONIC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    JOHNSON & JOHNSON
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    STRYKER
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BOSTON SCIENTIFIC CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    ABBOTT
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    ZIMMER BIOMET
    - Business overview
    - Products offered
    - Recent developments
    B. BRAUN SE
    - Business overview
    - Products offered
    GLOBUS MEDICAL
    - Business overview
    - Products offered
    - Recent developments
    INTEGRA LIFESCIENCES CORPORATION
    - Business overview
    - Products offered
    SIEMENS HEALTHINEERS AG
    - Business overview
    - Products offered
    - Recent developments
    FUJIFILM CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    KONINKLIJKE PHILIPS N.V.
    - Business overview
    - Products offered
    - Recent developments
    INTUITIVE SURGICAL OPERATIONS, INC.
    - Business overview
    - Products offered
    - Recent developments
    KARL STORZ SE & CO. KG
    - Business overview
    - Products offered
    - Recent developments
    GE HEALTHCARE
    - Business overview
    - Products offered
    - Recent developments
  • 11.2 OTHER PLAYERS
    NIPRO
    SMITH+NEPHEW
    GETINGE
    CONMED CORPORATION
    TELEFLEX INCORPORATED
    OLYMPUS CORPORATION
    COOPERSURGICAL, INC.
    APPLIED MEDICAL RESOURCES CORPORATION
    OTU MEDICAL
    ATMOS MEDIZINTECHNIK GMBH & CO. KG
APPENDIX
378
  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 MINIMALLY INVASIVE SURGERY MARKET: INCLUSIONS & EXCLUSIONS
  • TABLE 2 STANDARD CURRENCY CONVERSION RATES
  • TABLE 3 MINIMALLY INVASIVE SURGERY MARKET: STUDY ASSUMPTIONS
  • TABLE 4 MINIMALLY INVASIVE SURGERY MARKET: RISK ANALYSIS
  • TABLE 5 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2019–2024 (USD THOUSAND)
  • TABLE 6 EXPORT DATA FOR HS CODE 9018, BY COUNTRY, 2019–2024 (USD THOUSAND)
  • TABLE 7 MINIMALLY INVASIVE SURGERY MARKET: PORTER’S FIVE FORCES
  • TABLE 8 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR MINIMALLY INVASIVE SURGICAL PRODUCTS
  • TABLE 9 KEY BUYING CRITERIA FOR MAJOR MINIMALLY INVASIVE SURGICAL PRODUCTS
  • TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 CLASSIFICATION OF MEDICAL DEVICES BY US FDA
  • TABLE 16 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 17 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 18 CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES IN JAPAN
  • TABLE 19 NMPA MEDICAL DEVICES CLASSIFICATION
  • TABLE 20 AVERAGE SELLING PRICE TREND OF MINIMALLY INVASIVE SURGICAL PRODUCTS, BY KEY PLAYER, 2022–2024 (USD)
  • TABLE 21 AVERAGE SELLING PRICE TREND OF MINIMALLY INVASIVE SURGICAL PRODUCTS, BY REGION, 2022–2024 (USD)
  • TABLE 22 MINIMALLY INVASIVE SURGERY MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026
  • TABLE 23 MINIMALLY INVASIVE SURGERY MARKET: UNMET NEEDS/END-USER EXPECTATIONS
  • TABLE 24 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 25 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR ORTHODONTIC SUPPLIES
  • TABLE 26 MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 27 MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 28 MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 29 HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 30 HANDHELD INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 31 TUBULAR RETRACTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 32 DILATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 33 SUTURING INSTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 34 PROBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 35 LASER FIBER DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 36 LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 37 LAPAROSCOPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 38 LAPAROSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 39 TROCARS & CANNULAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 40 GRASPERS & DISSECTORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 41 INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 42 INFLATION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 43 BALLOON CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 44 BALLON INFLATION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 45 GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 46 GUIDING DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 47 GUIDING CATHETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 48 GUIDEWIRES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 49 MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 50 MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 51 ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 52 CT SCANNERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 53 MRI SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 54 X-RAY SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 55 OTHER IMAGING & VISUALIZATION SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 56 MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 57 MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 58 ELECTROCAUTERY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 59 ELECTROSURGICAL GENERATORS & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 60 MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 61 MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 62 RIGID ENDOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 63 FLEXIBLE ENDOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 64 MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 65 MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 66 ROBOTIC SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 67 ROBOTIC INTRUMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 68 ROBOTIC SOFTWARE & SERVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 69 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 70 MINIMALLY INVASIVE GASTROINTESTINAL & ABDOMINAL SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 71 MINIMALLY INVASIVE CARDIOTHORACIC SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 72 MINIMALLY INVASIVE ORTHOPEDIC SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 73 MINIMALLY INVASIVE VASCULAR SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 74 MINIMALLY INVASIVE GYNECOLOGICAL SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 75 MINIMALLY INVASIVE ONCOLOGICAL SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 76 MINIMALLY INVASIVE NEUROLOGICAL SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 77 MINIMALLY INVASIVE UROLOGICAL SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 78 MINIMALLY INVASIVE ENT & RESPIRATORY SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 79 MINIMALLY INVASIVE COSMETIC SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 80 MINIMALLY INVASIVE DENTAL SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 81 MINIMALLY INVASIVE OTHER SURGERIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 82 MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 83 MINIMALLY INVASIVE SURGERY MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 84 MINIMALLY INVASIVE SURGERY MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 85 MINIMALLY INVASIVE SURGERY MARKET FOR CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 86 MINIMALLY INVASIVE SURGERY MARKET FOR EMERGENCY & TRAUMA CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 87 MINIMALLY INVASIVE SURGERY MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 88 MINIMALLY INVASIVE SURGERY MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 89 MINIMALLY INVASIVE SURGERY MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
  • TABLE 90 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 91 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY TYPE, 2023–2030 (THOUSAND UNITS)
  • TABLE 92 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 93 NORTH AMERICA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 94 NORTH AMERICA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 95 NORTH AMERICA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 96 NORTH AMERICA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 97 NORTH AMERICA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 98 NORTH AMERICA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 99 NORTH AMERICA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 100 NORTH AMERICA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 101 NORTH AMERICA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 102 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 103 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 104 US: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 105 US: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 106 US: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 107 US: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 108 US: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 109 US: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 110 US: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 111 US: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 112 US: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 113 US: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 114 US: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 115 US: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 116 CANADA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 117 CANADA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 118 CANADA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 119 CANADA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 120 CANADA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 121 CANADA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 122 CANADA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 123 CANADA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 124 CANADA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 125 CANADA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 126 CANADA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 127 CANADA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 128 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 129 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
  • TABLE 130 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 131 EUROPE: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 132 EUROPE: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 133 EUROPE: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 134 EUROPE: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 135 EUROPE: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 136 EUROPE: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 137 EUROPE: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 138 EUROPE: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 139 EUROPE: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 140 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 141 EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 142 GERMANY: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 143 GERMANY: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 144 GERMANY: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 145 GERMANY: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 146 GERMANY: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 147 GERMANY: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 148 GERMANY: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 149 GERMANY: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 150 GERMANY: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 151 GERMANY: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 152 GERMANY: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 153 GERMANY: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 154 UK: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 155 UK: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 156 UK: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 157 UK: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 158 UK: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 159 UK: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 160 UK: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 161 UK: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 162 UK: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 163 UK: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 164 UK: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 165 UK: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 166 FRANCE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 167 FRANCE: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 168 FRANCE: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 169 FRANCE: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 170 FRANCE: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 171 FRANCE: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 172 FRANCE: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 173 FRANCE: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 174 FRANCE: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 175 FRANCE: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 176 FRANCE: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 177 FRANCE: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 178 ITALY: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 179 ITALY: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 180 ITALY: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 181 ITALY: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 182 ITALY: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 183 ITALY: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 184 ITALY: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 185 ITALY: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 186 ITALY: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 187 ITALY: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 188 ITALY: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 189 ITALY: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 190 SPAIN: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 191 SPAIN: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 192 SPAIN: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 193 SPAIN: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 194 SPAIN: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 195 SPAIN: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 196 SPAIN: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 197 SPAIN: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 198 SPAIN: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 199 SPAIN: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 200 SPAIN: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 201 SPAIN: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 202 REST OF EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 203 REST OF EUROPE: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 204 REST OF EUROPE: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 205 REST OF EUROPE: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 206 REST OF EUROPE: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 207 REST OF EUROPE: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 208 REST OF EUROPE: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 209 REST OF EUROPE: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 210 REST OF EUROPE: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 211 REST OF EUROPE: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 212 REST OF EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 213 REST OF EUROPE: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 214 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 215 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (THOUSAND UNITS)
  • TABLE 216 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 217 ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 218 ASIA PACIFIC: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 219 ASIA PACIFIC: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 220 ASIA PACIFIC: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 221 ASIA PACIFIC: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 222 ASIA PACIFIC: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 223 ASIA PACIFIC: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 224 ASIA PACIFIC: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 225 ASIA PACIFIC: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 226 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 227 ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 228 CHINA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 229 CHINA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 230 CHINA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 231 CHINA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 232 CHINA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 233 CHINA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 234 CHINA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 235 CHINA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 236 CHINA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 237 CHINA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 238 CHINA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 239 CHINA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 240 INDIA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 241 INDIA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 242 INDIA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 243 INDIA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 244 INDIA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 245 INDIA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 246 INDIA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 247 INDIA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 248 INDIA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 249 INDIA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 250 INDIA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 251 INDIA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 252 JAPAN: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 253 JAPAN: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 254 JAPAN: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 255 JAPAN: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 256 JAPAN: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 257 JAPAN: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 258 JAPAN: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 259 JAPAN: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 260 JAPAN: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 261 JAPAN: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 262 JAPAN: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 263 JAPAN: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 264 SOUTH KOREA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 265 SOUTH KOREA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 266 SOUTH KOREA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 267 SOUTH KOREA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 268 SOUTH KOREA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 269 SOUTH KOREA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 270 SOUTH KOREA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 271 SOUTH KOREA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 272 SOUTH KOREA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 273 SOUTH KOREA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 274 SOUTH KOREA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 275 SOUTH KOREA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 276 AUSTRALIA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 277 AUSTRALIA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 278 AUSTRALIA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 279 AUSTRALIA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 280 AUSTRALIA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 281 AUSTRALIA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 282 AUSTRALIA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 283 AUSTRALIA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 284 AUSTRALIA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 285 AUSTRALIA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 286 AUSTRALIA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 287 AUSTRALIA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 288 REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 289 REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 290 REST OF ASIA PACIFIC: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 291 REST OF ASIA PACIFIC: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 292 REST OF ASIA PACIFIC: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 293 REST OF ASIA PACIFIC: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 294 REST OF ASIA PACIFIC: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 295 REST OF ASIA PACIFIC: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 296 REST OF ASIA PACIFIC: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 297 REST OF ASIA PACIFIC: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 298 REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 299 REST OF ASIA PACIFIC: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 300 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 301 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (THOUSAND UNITS)
  • TABLE 302 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 303 LATIN AMERICA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 304 LATIN AMERICA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 305 LATIN AMERICA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 306 LATIN AMERICA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 307 LATIN AMERICA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 308 LATIN AMERICA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 309 LATIN AMERICA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 310 LATIN AMERICA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 311 LATIN AMERICA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 312 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 313 LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 314 BRAZIL: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 315 BRAZIL: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 316 BRAZIL: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 317 BRAZIL: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 318 BRAZIL: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 319 BRAZIL: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 320 BRAZIL: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 321 BRAZIL: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 322 BRAZIL: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 323 BRAZIL: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 324 BRAZIL: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 325 BRAZIL: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 326 MEXICO: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 327 MEXICO: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 328 MEXICO: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 329 MEXICO: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 330 MEXICO: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 331 MEXICO: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 332 MEXICO: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 333 MEXICO: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 334 MEXICO: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 335 MEXICO: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 336 MEXICO: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 337 MEXICO: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 338 REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 339 REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 340 REST OF LATIN AMERICA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 341 REST OF LATIN AMERICA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 342 REST OF LATIN AMERICA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 343 REST OF LATIN AMERICA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 344 REST OF LATIN AMERICA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 345 REST OF LATIN AMERICA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 346 REST OF LATIN AMERICA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 347 REST OF LATIN AMERICA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 348 REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 349 REST OF LATIN AMERICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 350 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 351 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
  • TABLE 352 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 353 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 354 MIDDLE EAST & AFRICA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 355 MIDDLE EAST & AFRICA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 356 MIDDLE EAST & AFRICA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 357 MIDDLE EAST & AFRICA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 358 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 359 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 360 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 361 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 362 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 363 MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 364 GCC COUNTRIES: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 365 GCC COUNTRIES: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 366 GCC COUNTRIES: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 367 GCC COUNTRIES: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 368 GCC COUNTRIES: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 369 GCC COUNTRIES: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 370 GCC COUNTRIES: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 371 GCC COUNTRIES: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 372 GCC COUNTRIES: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 373 GCC COUNTRIES: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 374 GCC COUNTRIES: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 375 GCC COUNTRIES: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 376 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 377 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 378 REST OF MIDDLE EAST & AFRICA: HANDHELD INSTRUMENTS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 379 REST OF MIDDLE EAST & AFRICA: LAPAROSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 380 REST OF MIDDLE EAST & AFRICA: INFLATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 381 REST OF MIDDLE EAST & AFRICA: GUIDING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 382 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE IMAGING & VISUALIZATION SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 383 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE ELECTROSURGICAL DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 384 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE ENDOSCOPY DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 385 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE MEDICAL ROBOTICS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 386 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
  • TABLE 387 REST OF MIDDLE EAST & AFRICA: MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 388 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN MINIMALLY INVASIVE SURGERY MARKET
  • TABLE 389 MINIMALLY INVASIVE SURGERY MARKET: DEGREE OF COMPETITION
  • TABLE 390 MINIMALLY INVASIVE SURGERY MARKET: REGION FOOTPRINT
  • TABLE 391 MINIMALLY INVASIVE SURGERY MARKET: PRODUCT FOOTPRINT
  • TABLE 392 MINIMALLY INVASIVE SURGERY MARKET: APPLICATION FOOTPRINT
  • TABLE 393 MINIMALLY INVASIVE SURGERY MARKET: END-USER FOOTPRINT
  • TABLE 394 MINIMALLY INVASIVE SURGERY MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
  • TABLE 395 MINIMALLY INVASIVE SURGERY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY PRODUCT AND REGION
  • TABLE 396 MINIMALLY INVASIVE SURGERY MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JULY 2025
  • TABLE 397 MINIMALLY INVASIVE SURGERY MARKET: DEALS, JANUARY 2022–JULY 2025
  • TABLE 398 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 399 MEDTRONIC: PRODUCTS OFFERED
  • TABLE 400 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2022–JULY 2025
  • TABLE 401 MEDTRONIC: EXPANSIONS, JANUARY 2022–JULY 2025
  • TABLE 402 JOHNSON & JOHNSON: COMPANY OVERVIEW
  • TABLE 403 JOHNSON & JOHNSON: PRODUCTS OFFERED
  • TABLE 404 JOHNSON & JOHNSON: PRODUCT APPROVALS, JANUARY 2022–JULY 2025
  • TABLE 405 JOHNSON & JOHNSON: DEALS, JANUARY 2022–JULY 2025
  • TABLE 406 STRYKER: COMPANY OVERVIEW
  • TABLE 407 STRYKER: PRODUCTS OFFERED
  • TABLE 408 STRYKER: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JULY 2025
  • TABLE 409 STRYKER: DEALS, JANUARY 2022–JULY 2025
  • TABLE 410 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
  • TABLE 411 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED
  • TABLE 412 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2022–JULY 2025
  • TABLE 413 ABBOTT: COMPANY OVERVIEW
  • TABLE 414 ABBOTT: PRODUCTS OFFERED
  • TABLE 415 ABBOTT: DEALS, JANUARY 2022–JULY 2025
  • TABLE 416 ZIMMER BIOMET: COMPANY OVERVIEW
  • TABLE 417 ZIMMER BIOMET: PRODUCTS OFFERED
  • TABLE 418 ZIMMER BIOMET: PRODUCT APPROVALS, JANUARY 2022–JULY 2025
  • TABLE 419 ZIMMER BIOMET: DEALS, JANUARY 2022–JULY 2025
  • TABLE 420 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 421 B BRAUN SE: PRODUCTS OFFERED
  • TABLE 422 GLOBUS MEDICAL: COMPANY OVERVIEW
  • TABLE 423 GLOBUS MEDICAL: PRODUCTS OFFERED
  • TABLE 424 GLOBUS MEDICAL: DEALS, JANUARY 2022–JULY 2025
  • TABLE 425 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW
  • TABLE 426 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED
  • TABLE 427 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
  • TABLE 428 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED
  • TABLE 429 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025
  • TABLE 430 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2022–JULY 2025
  • TABLE 431 FUJIFILM CORPORATION: COMPANY OVERVIEW
  • TABLE 432 FUJIFILM CORPORATION: PRODUCTS OFFERED
  • TABLE 433 FUJIFILM CORPORATION: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JULY 2025
  • TABLE 434 FUJIFILM CORPORATION: DEALS, JANUARY 2022–JULY 2025
  • TABLE 435 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 436 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
  • TABLE 437 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–JULY 2025
  • TABLE 438 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2022–JULY 2025
  • TABLE 439 INTUITIVE SURGICAL OPERATIONS, INC.: COMPANY OVERVIEW
  • TABLE 440 INTUITIVE SURGICAL OPERATIONS, INC.: PRODUCTS OFFERED
  • TABLE 441 INTUITIVE SURGICAL OPERATIONS, INC.: PRODUCT APPROVALS, JANUARY 2022–JULY 2025
  • TABLE 442 KARL STORZ SE & CO. KG: COMPANY OVERVIEW
  • TABLE 443 KARL STORZ SE & CO. KG: PRODUCTS OFFERED
  • TABLE 444 KARL STORZ SE & CO. KG: DEALS, JANUARY 2022–JULY 2025
  • TABLE 445 KARL STORZ SE & CO. KG: EXPANSIONS, JANUARY 2022–JULY 2025
  • TABLE 446 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 447 GE HEALTHCARE: PRODUCTS OFFERED
  • TABLE 448 GE HEALTHCARE: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025
  • TABLE 449 GE HEALTHCARE: DEALS, JANUARY 2022–JULY 2025
  • TABLE 450 NIPRO: COMPANY OVERVIEW
  • TABLE 451 SMITH+NEPHEW: COMPANY OVERVIEW
  • TABLE 452 GETINGE: COMPANY OVERVIEW
  • TABLE 453 CONMED CORPORATION: COMPANY OVERVIEW
  • TABLE 454 TELEFLEX INCORPORATED: COMPANY OVERVIEW
  • TABLE 455 OLYMPUS CORPORATION: COMPANY OVERVIEW
  • TABLE 456 COOPERSURGICAL, INC.: COMPANY OVERVIEW
  • TABLE 457 APPLIED MEDICAL RESOURCES CORPORATION: COMPANY OVERVIEW
  • TABLE 458 OTU MEDICAL: COMPANY OVERVIEW
  • TABLE 459 ATMOS MEDIZINTECHNIK GMBH & CO. KG: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 MINIMALLY INVASIVE SURGERY MARKET SEGMENTATION & REGIONAL SCOPE
  • FIGURE 2 MINIMALLY INVASIVE SURGERY MARKET: YEARS CONSIDERED
  • FIGURE 3 MINIMALLY INVASIVE SURGERY MARKET: RESEARCH DESIGN
  • FIGURE 4 MINIMALLY INVASIVE SURGERY MARKET: KEY DATA FROM SECONDARY SOURCES
  • FIGURE 5 MINIMALLY INVASIVE SURGERY MARKET: KEY PRIMARY SOURCES
  • FIGURE 6 MINIMALLY INVASIVE SURGERY MARKET: KEY DATA FROM PRIMARY SOURCES
  • FIGURE 7 MINIMALLY INVASIVE SURGERY MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS
  • FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 9 MINIMALLY INVASIVE SURGERY MARKET SIZE APPROACH: REVENUE SHARE ANALYSIS
  • FIGURE 10 MINIMALLY INVASIVE SURGERY MARKET: TOP-DOWN APPROACH
  • FIGURE 11 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MINIMALLY INVASIVE SURGERY MARKET (2025–2030)
  • FIGURE 12 MINIMALLY INVASIVE SURGERY MARKET: CAGR PROJECTIONS
  • FIGURE 13 MINIMALLY INVASIVE SURGERY MARKET: DATA TRIANGULATION METHODOLOGY
  • FIGURE 14 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 MINIMALLY INVASIVE SURGERY MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 16 MINIMALLY INVASIVE SURGERY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 MINIMALLY INVASIVE SURGERY MARKET: REGIONAL SNAPSHOT
  • FIGURE 18 HIGH VOLUME OF SURGICAL PROCEDURES AND PREFERENCE FOR MINIMALLY INVASIVE SURGICAL PROCEDURES TO DRIVE MARKET
  • FIGURE 19 US AND HOSPITALS SEGMENT COMMANDED LARGEST MARKET SHARE IN 2024
  • FIGURE 20 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 21 NORTH AMERICA TO GROW AT HIGHEST GROWTH RATE FROM 2025 TO 2030
  • FIGURE 22 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES DURING STUDY PERIOD
  • FIGURE 23 MINIMALLY INVASIVE SURGERY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 24 MINIMALLY INVASIVE SURGERY MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 25 MINIMALLY INVASIVE SURGERY MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 26 MINIMALLY INVASIVE SURGERY MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 27 MINIMALLY INVASIVE SURGERY MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 28 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR MINIMALLY INVASIVE SURGICAL PRODUCTS
  • FIGURE 29 KEY BUYING CRITERIA FOR MAJOR MINIMALLY INVASIVE SURGICAL PRODUCTS
  • FIGURE 30 TOP 10 COMPANIES WITH HIGHEST PATENT OWNERSHIPS/APPLICATIONS AND NUMBER OF PATENTS GRANTED (JANUARY 2015–JULY 2025)
  • FIGURE 31 TOP APPLICANT COUNTRIES/REGIONS FOR MINIMALLY INVASIVE SURGERY PATENTS (JANUARY 2014−MAY 2025)
  • FIGURE 32 ENDOSCOPY EQUIPMENT MARKET OVERVIEW
  • FIGURE 33 MINIMALLY INVASIVE SURGERY MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • FIGURE 34 MINIMALLY INVASIVE SURGERY MARKET: FUNDING AND NUMBER OF DEALS (2019–2023)
  • FIGURE 35 IMPACT OF AI/GEN AI ON MINIMALLY INVASIVE SURGERY MARKET
  • FIGURE 36 MINIMALLY INVASIVE SURGERY MARKET: GEOGRAPHIC SNAPSHOT
  • FIGURE 37 NORTH AMERICA: MINIMALLY INVASIVE SURGERY MARKET SNAPSHOT
  • FIGURE 38 EUROPE: MINIMALLY INVASIVE SURGERY MARKET SNAPSHOT
  • FIGURE 39 REVENUE ANALYSIS OF KEY PLAYERS IN MINIMALLY INVASIVE SURGERY MARKET (2022–2024)
  • FIGURE 40 MARKET SHARE ANALYSIS OF KEY PLAYERS IN MINIMALLY INVASIVE SURGERY MARKET (2024)
  • FIGURE 41 MINIMALLY INVASIVE SURGERY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 42 MINIMALLY INVASIVE SURGERY MARKET: COMPANY FOOTPRINT
  • FIGURE 43 MINIMALLY INVASIVE SURGERY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 44 EV/EBITDA OF KEY VENDORS
  • FIGURE 45 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 46 MINIMALLY INVASIVE SURGERY MARKET: BRAND/PRODUCTCOMPARATIVE ANALYSIS
  • FIGURE 47 MEDTRONIC: COMPANY SNAPSHOT
  • FIGURE 48 JOHNSON & JOHNSON: COMPANY SNAPSHOT
  • FIGURE 49 STRYKER: COMPANY SNAPSHOT
  • FIGURE 50 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • FIGURE 51 ABBOTT: COMPANY SNAPSHOT
  • FIGURE 52 ZIMMER BIOMET: COMPANY SNAPSHOT
  • FIGURE 53 B. BRAUN SE: COMPANY SNAPSHOT
  • FIGURE 54 GLOBUS MEDICAL: COMPANY SNAPSHOT
  • FIGURE 55 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
  • FIGURE 56 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
  • FIGURE 57 FUJIFILM CORPORATION: COMPANY SNAPSHOT
  • FIGURE 58 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • FIGURE 59 INTUITIVE SURGICAL OPERATIONS, INC.: COMPANY SNAPSHOT
  • FIGURE 60 GE HEALTHCARE: COMPANY SNAPSHOT

 

The study involved key activities in estimating the current size of the minimally invasive surgery market. Extensive secondary research was conducted to gather information on the industry. The next step was to validate these findings, assumptions, and market size with industry experts across the value chain through primary research. Different methods, such as top-down and bottom-up approaches, were used to estimate the overall market size. Subsequently, market segmentation and data triangulation techniques were applied to determine the size of various segments and subsegments within the MIS market.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global minimally invasive surgery market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

During the primary research process, various sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. The primary sources on the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from various companies and organizations in the minimally invasive surgery market. On the demand side, primary sources include ambulatory surgical centers, hospitals, clinics, and other end users. The primary research was conducted to validate market segmentation, identify key players, and gather insights on important industry trends and market dynamics.

A breakdown of the primary respondents is provided below:

Minimally Invasive Surgery Market

*C-level primaries include CEOs, CFOs, COOs, and VPs.

Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = USD 1.00 billion.

Source: MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

For the global market value, annual revenues were estimated based on revenue mapping of leading product manufacturers and OEMs active in the worldwide minimally invasive surgery market. All major product manufacturers were identified at the global and/or country or regional level. Revenue mapping for the respective business segments or sub-segments was performed for the key players. Also, the global minimally invasive surgery market was split into various segments and sub-segments based on:

  • List of major players operating in the product market at the regional and/or country level
  • Product mapping of various minimally invasive surgery manufacturers at the regional and/or country level
  • Mapping of annual revenue generated by listed major players from minimally invasive surgery (or the nearest reported business unit/product category)
  • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
  • Summation of the market value of all segments/subsegments to arrive at the global minimally invasive surgery market

The data mentioned above was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Minimally Invasive Surgery Market

Data Triangulation

After determining the overall size of the global minimally invasive surgery market using the methodology mentioned above, the market was divided into several segments and subsegments. Data triangulation and market breakdown techniques were used, where applicable, to complete the overall market analysis and obtain precise market value data for the key segments and subsegments. The extrapolated market data was then triangulated by examining various macro indicators and regional trends from both demand- and supply-side participants.

Market Definition

Minimally invasive surgery (MIS) is a procedure that causes little to no trauma or injury to a patient. MIS is performed through a cannula using lasers, endoscopes, or laparoscopes. It involves less bleeding, reduced anesthesia, less pain, and minimal scarring compared to other procedures. The surgical instruments used to make tiny incisions and carry out MIS are minimally invasive. The primary products used for minimally invasive surgery are surgical tools, imaging and visualization systems, electrosurgical devices, endoscopy devices, and medical robotics.

Stakeholders

  • Manufacturers and Distributors of Minimally Invasive Surgical Instruments
  • Healthcare Institutions (Hospitals and Clinics)
  • Ambulatory Surgery Centers (ASCs)
  • Healthcare Institutions (hospitals and outpatient clinics)
  • Research Institutions
  • Research and Consulting Firms
  • Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)
  • Academic Medical Centers and Universities
  • Market Research and Consulting Firms
  • Clinical Research Organizations
  • Research Laboratories and Academic Institutes
  • Minimally Invasive Surgical Instrument Service Providers

Report Objectives

  • To describe, analyze, and forecast the minimally invasive surgery market by product, application, end user, and region
  • To describe and forecast the minimally invasive surgery market in key regions—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the market growth
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
  • To profile key players and comprehensively analyze their market shares and core competencies2 in the minimally invasive surgery market
  • To analyze competitive developments such as partnerships, agreements & acquisitions, product launches, product approvals, and expansions in the minimally invasive surgery market
  • To analyze the impact of AI/Gen AI on the minimally invasive surgery market in terms of its capabilities, potential, use cases, and future

Available customizations:

With the given market data, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

Geographic Analysis

  • Further breakdown of the Rest of European minimally invasive surgery market into Russia, Switzerland, Denmark, Austria, and others
  • Further breakdown of the Rest of Asia Pacific minimally invasive surgery market into South Korea, Taiwan, and others
  • Further breakdown of the Rest of Latin American minimally invasive surgery market into Argentina, Colombia, Chile, Ecuador, and others
  • Further breakdown of the Southeast Asian minimally invasive surgery market into Malaysia, Singapore, Australia, New Zealand, and others

Competitive Landscape Assessment

  • Market share analysis, by region (North America and Europe), which provides market shares of the top 3–5 key players in the minimally invasive surgery market
  • Competitive leadership mapping for established players in the US

Previous Versions of this Report

Minimally Invasive Surgery Market by Product (Robotics, Imaging, Instrument (Handheld, inflation, Guiding, electrosurgery, endoscopy)), Application (CVD, thoracic, neuro, ENT, OB/GYN, orthopedic), Enduser - Global Forecast to 2029

Report Code MD 1250
Published in Mar, 2024, By MarketsandMarkets™

Minimally Invasive Medical Robotics, Imaging & Visualization Systems & Surgical Instruments Market Forecasts to 2016 (DA VINCI, Robodoc, Spine Assist, Neuromate, Ultrasound, CT, MRI, X-RAY Imaging, Electrosurgical Devices,  Handheld Instruments, Guiding Devices, Inflation Systems & Auxiliary Devices) Global Trends & Competitive Analysis

Report Code MD 1250
Published in Jul, 2012, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.

By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Minimally Invasive Surgery Market

©2025 Marketsandmarkets Research Private Ltd. All Rights Reserved.

DMCA.com Protection Status